Meetings Events & Conference Coordinators Masters in Thoracic Oncology Summit 2023
Format: 52 videos, size: 4.51 GB
Course Audience: surgical and radiation oncologists, Pulmonologists, Radiologists ,Thoracic surgeons, Pathologists
Overview:
The Masters in Thoracic Oncology Summit 2023 organized by Meetings Events & Conference Coordinators (MECC) is a key event for professionals in the field of thoracic oncology. This summit is designed to address and discuss the current challenges and future directions in lung cancer treatment and research.
Target Audience:
- Medical, surgical, and radiation oncologists
- Pulmonologists
- Radiologists
- Thoracic surgeons
- Pathologists
- Nurse practitioners and nurses specializing in thoracic oncology
- Researchers and clinical scientists in the field of lung cancer
The summit includes sessions on the latest discoveries in genetics and epigenomics, diagnosis, minimal residual disease (MRD), monitoring for recurrence, and assessment of therapeutic success with targeted therapy and immunotheray
ALK in Front Line Therapy Second or Third Generation TKI Inhibitors What Can Help Us to Choose the Best Therapeutic Agent (Video MP4 Format)
Anti-CEACAM and ROR ADCs (Video MP4 Format)Best Approaches for First Line EGFRm NSCLC (Video MP4 Format)Best Surgical Approaches for Stage III NSCLC (Video MP4 Format)Biomarkers for Perioperative Immunotherapy (Video MP4 Format)Brain Radiotherapy in Small Cell Lung Cancer When (Video MP4 Format)Cellular Therapies in NSCLC Is it feasible (Video MP4 Format)ctDNA Analyses in Early Detection Methylation, Proteomics and Other Efforts for Early Lung Cancer Detection (Video MP4 Format)Deciphering the Mechanism of Resistance to First Generation KRAS Inhibitors (Video MP4 Format)Developing New Anti-CTL4s for NSCLC Is There Any Role (Video MP4 Format)Early Stage Resectable Lung Cancer Adjuvant Immunotherapy (Video MP4 Format)Exon 20 and Uncommon EGFR Sensitive Mutations (Video MP4 Format)Frontline What are We Adding to Checkpoint Inhibitors and Chemotherapy (Video MP4 Format)Future Challenges for lmmunotherapy in the Fight Against NSCLC (Video MP4 Format)Health Care Disparities in Lung Cancer Genomic Profiling Has Precision Oncology Widened the Gap (Video MP4 Format)HER-3 as a New Target in NSCLC (Video MP4 Format)HER2 Tx in Advanced NSCLC From TKls to ADCs (Video MP4 Format)How to Rescue Patients from Osimertinib Resistance (Video MP4 Format)How to Start a Lung Cancer Screening Program (Video MP4 Format)Improving Targeted Therapies for Patients with Lung Cancers Where are the gaps and ways to fill them (Video MP4 Format)KRAS mutant NSCLC What is the Standard of Care Now (Video MP4 Format)Lack of Equity in Clinical Outcomes in Blacks and Hispanics with NSCLC (Video MP4 Format)Limited Stage SCLC 2023 (Video MP4 Format)Management of LA-NSCLC in Pts with PD-L1 – 1% or Oncogenic Drivers (Video MP4 Format)Mechanisms of Resistance to ALK Inhibitors (Video MP4 Format)Minimal Residual Disease as Detected by Liquid Biopsy Where are We Going (Video MP4 Format)MRD to Decide Perioperative Management in the Era of Immuno-Oncology (Video MP4 Format)Neoadjuvant Immunotherapy Position (Video MP4 Format)Novel Therapies for Thymic Malignancies (Video MP4 Format)NRG1 as a Target in NSCLC (Video MP4 Format)Optimal Management of Extensive SCLC (1st and 2nd Line) (Video MP4 Format)Overcoming T-Cell Exhaustion (Video MP4 Format)Pan-KRAS Inhibitors Where are We Going (Video MP4 Format)PARP Inhibitors in SCLC (Video MP4 Format)Predictive Biomarkers in Small Cell Lung Carcinoma (Video MP4 Format)Radiation Induced Immune Responses in NSCLC (Video MP4 Format)RET and NTRK The Good, The Bad, The Ugly…. and What’s Coming Up (Video MP4 Format)Role of Interleukins to Improve Efficacy of Immunotherapy (Video MP4 Format)Role of Radiotherapy in TIME Good Bad Don’t know (Video MP4 Format)ROS1 and BRAf Inhibitors New Developments (Video MP4 Format)Stage III Non-Surgical NSCLC Optimal Radiation Therapy Treatment Approach (Video MP4 Format)Strategies to Target Minimal Residual Disease in Lung Cancer (Video MP4 Format)Surgery for Malignant Pleural Mesothelioma (Video MP4 Format)Systemic Therapies for Mesothelioma (Video MP4 Format)The Importance of TIME in Cancer Treatment How to Target It (Video MP4 Format)The New Role of Microbiome in Lung Cancer Immunotherapy (Video MP4 Format)The Role of Co-Mutations in Immunotherapy Response in NSCLC (Video MP4 Format)The Role of SHP-2 Inhibitors Alone or in Combination (Video MP4 Format)TROP-2 and AXL as Targets in NSCLC (Video MP4 Format)Updates in Bispecific Antibodies in NSCLC (Video MP4 Format)What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Video MP4 Format)What’s After PACIFIC Can We Raise the Bar (Video MP4 Format)